{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:16:59Z","timestamp":1793024219093,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41440-025-02374-x","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T08:34:58Z","timestamp":1759739698000},"page":"3091-3100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Elevated level of estimated small dense LDL cholesterol is independently associated with the development of hypertension, regardless of LDL cholesterol level"],"prefix":"10.1038","volume":"48","author":[{"given":"Hiroki","family":"Aida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Kawaharata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Matsumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemichi","family":"Kouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagisa","family":"Hanawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"2374_CR1","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2374_CR2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217\u201323.","journal-title":"Lancet"},{"key":"2374_CR3","first-page":"e1046","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1046\u2013e81.","journal-title":"Circulation"},{"key":"2374_CR4","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/ckj\/sfac111","volume":"15","author":"A Osanami","year":"2022","unstructured":"Osanami A, Tanaka M, Furuhashi M, Ohnishi H, Hanawa N, Yamashita T, et al. Increased LDL-cholesterol level is associated with deterioration of renal function in males. Clin Kidney J. 2022;15:1888\u201395.","journal-title":"Clin Kidney J"},{"key":"2374_CR5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/0002-8703(88)90220-7","volume":"116","author":"G Assmann","year":"1988","unstructured":"Assmann G, Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and\/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J. 1988;116:1713\u201324.","journal-title":"Am Heart J"},{"key":"2374_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOL.0000000000000963","volume":"36","author":"J Hernando-Redondo","year":"2025","unstructured":"Hernando-Redondo J, Nino OC, Fito M. Atherogenic low-density lipoprotein and cardiovascular risk. Curr Opin Lipido. 2025;36:8\u201313.","journal-title":"Curr Opin Lipido"},{"key":"2374_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjcard.2025.02.034","volume":"245","author":"M Jha","year":"2025","unstructured":"Jha M, McCarthy IR, Gelfand EV. Lipoprotein(a) - From Biomarker To Therapy: A Review For The Clinician. Am J Cardiol. 2025;245:42\u201353.","journal-title":"Am J Cardiol"},{"key":"2374_CR8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","volume":"25","author":"T Hirano","year":"2018","unstructured":"Hirano T. Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb. 2018;25:771\u201382.","journal-title":"J Atheroscler Thromb"},{"key":"2374_CR9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","volume":"43","author":"KK Berneis","year":"2002","unstructured":"Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43:1363\u201379.","journal-title":"J Lipid Res"},{"key":"2374_CR10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/jdi.14398","volume":"16","author":"T Hirano","year":"2025","unstructured":"Hirano T. Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes. J Diab Investig. 2025;16:370\u201383.","journal-title":"J Diab Investig"},{"key":"2374_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","volume":"67","author":"RC Hoogeveen","year":"2021","unstructured":"Hoogeveen RC, Ballantyne CM. Residual cardiovascular risk at low LDL: Remnants, Lipoprotein(a), and inflammation. Clin Chem. 2021;67:143\u201353.","journal-title":"Clin Chem"},{"key":"2374_CR12","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.jacc.2021.04.059","volume":"77","author":"S Raposeiras-Roubin","year":"2021","unstructured":"Raposeiras-Roubin S, Rossello X, Oliva B, Fernandez-Friera L, Mendiguren JM, Andres V, et al. Triglycerides and residual atherosclerotic risk. J Am Coll Cardiol. 2021;77:3031\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"2374_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1373\/clinchem.2010.149559","volume":"57","author":"Y Ito","year":"2011","unstructured":"Ito Y, Fujimura M, Ohta M, Hirano T. Development of a homogeneous assay for measurement of small dense LDL cholesterol. Clin Chem. 2011;57:57\u201365.","journal-title":"Clin Chem"},{"key":"2374_CR14","doi-asserted-by":"crossref","unstructured":"Sato T, Tanaka M, Furuhashi M. Can small dense LDL cholesterol be estimated from the lipid profile? Curr Opin Lipidol. 2025;30:198\u2013202.","DOI":"10.1097\/MOL.0000000000000989"},{"key":"2374_CR15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/clinchem\/hvab048","volume":"67","author":"M Sampson","year":"2021","unstructured":"Sampson M, Wolska A, Warnick R, Lucero D, Remaley AT. A new equation based on the standard lipid panel for calculating small dense low-density Lipoprotein-cholesterol and its use as a risk-enhancer test. Clin Chem. 2021;67:987\u201397.","journal-title":"Clin Chem"},{"key":"2374_CR16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.5551\/jat.64578","volume":"31","author":"K Endo","year":"2024","unstructured":"Endo K, Kobayashi R, Tanaka M, Tanaka M, Akiyama Y, Sato T, et al. Validation of estimated small dense low-density lipoprotein cholesterol concentration in a Japanese general population. J Atheroscler Thromb. 2024;31:931\u201352.","journal-title":"J Atheroscler Thromb"},{"key":"2374_CR17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5551\/jat.64369","volume":"31","author":"M Inyaku","year":"2024","unstructured":"Inyaku M, Tanaka M, Sato T, Endo K, Mori K, Hosaka I, et al. Calculated small dense low-density lipoprotein cholesterol level is a predominant predictor for new onset of ischemic heart disease. J Atheroscler Thromb. 2024;31:232\u201348.","journal-title":"J Atheroscler Thromb"},{"key":"2374_CR18","doi-asserted-by":"crossref","unstructured":"Endo K, Tanaka M, Sato T, Inyaku M, Nakata K, Kawaharata W, et al. High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level- A 10-Year Cohort Study. Circ J. 2025;89:1182\u20139.","DOI":"10.1253\/circj.CJ-24-0770"},{"key":"2374_CR19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/jhh.2011.86","volume":"26","author":"YK Kim","year":"2012","unstructured":"Kim YK, Seo HS, Lee EM, Na JO, Choi CU, Lim HE, et al. Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome. J Hum Hypertens. 2012;26:670\u20136.","journal-title":"J Hum Hypertens"},{"key":"2374_CR20","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/s41440-023-01392-x","volume":"46","author":"M Tanaka","year":"2023","unstructured":"Tanaka M, Sato T, Endo K, Inyaku M, Mori K, Hosaka I, et al. An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort. Hypertens Res. 2023;46:2635\u201345.","journal-title":"Hypertens Res"},{"key":"2374_CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"2374_CR22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","volume":"5","author":"M Sampson","year":"2020","unstructured":"Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with Normolipidemia and\/or Hypertriglyceridemia. JAMA Cardiol. 2020;5:540\u20138.","journal-title":"JAMA Cardiol"},{"key":"2374_CR23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1253\/circj.66.987","volume":"66","author":"Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan, Japan Society for the Study of Obesity","year":"2002","unstructured":"Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan, Japan Society for the Study of Obesity. New criteria for \u2018obesity disease\u2019 in Japan. Circ J. 2002;66:987\u201392.","journal-title":"Circ J"},{"key":"2374_CR24","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diab Care. 2024;47:S20\u2013S42.","journal-title":"Diab Care"},{"key":"2374_CR25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.5551\/jat.GL2017","volume":"25","author":"M Kinoshita","year":"2018","unstructured":"Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, et al. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb. 2018;25:846\u2013984.","journal-title":"J Atheroscler Thromb"},{"key":"2374_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-018-1648-1","volume":"23","author":"Japanese Society of N.","year":"2019","unstructured":"Japanese Society of Nephrology. Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018. Clin Exp Nephrol. 2019;23:1\u201315.","journal-title":"Clin Exp Nephrol"},{"key":"2374_CR27","doi-asserted-by":"crossref","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","DOI":"10.1038\/bmt.2012.244"},{"key":"2374_CR28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.5551\/jat.RV22019","volume":"31","author":"A Higashiyama","year":"2024","unstructured":"Higashiyama A, Kohsaka S, Fujiyoshi A. Primary prevention of coronary and other cardiovascular diseases: a focused review. J Atheroscler Thromb. 2024;31:1113\u201328.","journal-title":"J Atheroscler Thromb"},{"key":"2374_CR29","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/eurheartj\/ehn061","volume":"29","author":"DE Laaksonen","year":"2008","unstructured":"Laaksonen DE, Niskanen L, Nyyssonen K, Lakka TA, Laukkanen JA, Salonen JT. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J. 2008;29:2561\u20138.","journal-title":"Eur Heart J"},{"key":"2374_CR30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003053","volume":"5","author":"T Otsuka","year":"2016","unstructured":"Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J Am Heart Assoc. 2016;5:e003053.","journal-title":"J Am Heart Assoc"},{"key":"2374_CR31","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Gesang P, Zhou Y, Ding K, Wan Y, Xiong H. Relationship between lipid levels, TyG, TyG-BMI index and hypertension in Tibetan population in Tibet, China based on restricted cubic spline model. BMC Public Health. 2024;24:3595.","journal-title":"BMC Public Health"},{"key":"2374_CR32","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/BF00401766","volume":"38","author":"SM Haffner","year":"1995","unstructured":"Haffner SM, Mykkanen L, Robbins D, Valdez R, Miettinen H, Howard BV, et al. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia. 1995;38:1328\u201336.","journal-title":"Diabetologia"},{"key":"2374_CR33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.ATV.17.7.1447","volume":"17","author":"L Mykkanen","year":"1997","unstructured":"Mykkanen L, Haffner SM, Rainwater DL, Karhapaa P, Miettinen H, Laakso M. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol. 1997;17:1447\u201353.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2374_CR34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2362.2002.00945.x","volume":"32","author":"D Panarotto","year":"2002","unstructured":"Panarotto D, Remillard P, Bouffard L, Maheux P. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest. 2002;32:84\u201392.","journal-title":"Eur J Clin Invest"},{"key":"2374_CR35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2011.04.007","volume":"22","author":"SH Choi","year":"2011","unstructured":"Choi SH, Ginsberg HN. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab. 2011;22:353\u201363.","journal-title":"Trends Endocrinol Metab"},{"key":"2374_CR36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.ATV.21.2.282","volume":"21","author":"M Guerin","year":"2001","unstructured":"Guerin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol. 2001;21:282\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2374_CR37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1464-5491.1991.tb01652.x","volume":"8","author":"C Baynes","year":"1991","unstructured":"Baynes C, Henderson AD, Anyaoku V, Richmond W, Hughes CL, Johnston DG, et al. The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med. 1991;8:560\u20136.","journal-title":"Diabet Med"},{"key":"2374_CR38","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bmj.322.7291.912","volume":"322","author":"G Beevers","year":"2001","unstructured":"Beevers G, Lip GY, O\u2019Brien E. ABC of hypertension: The pathophysiology of hypertension. BMJ. 2001;322:912\u20136.","journal-title":"BMJ"},{"key":"2374_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrcardio.2017.155","volume":"15","author":"ME Safar","year":"2018","unstructured":"Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018;15:97\u2013105.","journal-title":"Nat Rev Cardiol"},{"key":"2374_CR40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-2275(20)32065-4","volume":"41","author":"CJ Packard","year":"2000","unstructured":"Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res. 2000;41:305\u201318.","journal-title":"J Lipid Res"},{"key":"2374_CR41","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.ATV.17.4.786","volume":"17","author":"S Goulinet","year":"1997","unstructured":"Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17:786\u201396.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2374_CR42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.ATV.19.3.810","volume":"19","author":"L Chancharme","year":"1999","unstructured":"Chancharme L, Therond P, Nigon F, Lepage S, Couturier M, Chapman MJ. Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol. 1999;19:810\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2374_CR43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.20060218","volume":"203","author":"JW Heinecke","year":"2006","unstructured":"Heinecke JW. Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?. J Exp Med. 2006;203:813\u20136.","journal-title":"J Exp Med"},{"key":"2374_CR44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.110.168005","volume":"57","author":"AP Carson","year":"2011","unstructured":"Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension. 2011;57:1101\u20137.","journal-title":"Hypertension"},{"key":"2374_CR45","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ehjcvp\/pvac040","volume":"8","author":"J Tamargo","year":"2022","unstructured":"Tamargo J, Kaski JC, Kimura T, Barton JC, Yamamoto K, Komiyama M, et al. Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. Eur Heart J Cardiovasc Pharmacother. 2022;8:738\u201351.","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02374-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:01:49Z","timestamp":1764889309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2374"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02374-x","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}